UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12Aaron Lee, Adnan Tufail, Thomas Butt et al.|British Journal of Ophthalmology|2015Cited by 60